Graviti Furosemide Tablets Recall: Foreign Substance Hazard
Graviti Pharmaceuticals recalls 40mg furosemide tablets with foreign substance. Rx-only medication manufactured in India, lot FUB125042G, expires 05/2027. Consumers should contact pharmacy for guidance.
Recall notice
Presence of Foreign Substance
Contact the company
What happened, in plain English
Graviti Pharmaceuticals is recalling 40mg furosemide tablets that contain a foreign substance. This could pose a risk to patients taking the medication, so affected individuals should contact their pharmacy for guidance. Read more at govinfonow.com/recall/31557-graviti-furosemide-tablets-recall-foreign-substance-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/31557-graviti-furosemide-tablets-recall-foreign-substance-hazard · Updated August 17, 2026 · FDA enforcement record: FDA #D-0293-2026
Cite this page
“Graviti Furosemide Tablets Recall: Foreign Substance Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31557-graviti-furosemide-tablets-recall-foreign-substance-hazard. Based on FDA recall #D-0293-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0293-2026%22&limit=1).
Why it’s dangerous
The tablets contain a foreign substance that could cause harm when taken. This is a medication that requires a prescription and is used to treat conditions like fluid retention.
Who’s affected
Patients prescribed furosemide tablets by a healthcare provider. Those with the specific lot number FUB125042G are most at risk.
How to tell if you have this one
Check for the lot number FUB125042G on the packaging. The tablets are labeled as 40mg furosemide, USP, 1,000 tablets, Rx only, manufactured for Rising Pharmaceuticals Inc. in New Jersey.
- Brand
Graviti Pharmaceuticals- Category
Drug
What to do — step by step
Contact Pharmacy
Reach out to your pharmacy for guidance on next steps as the recall remedy is not specified.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 18 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0293-2026 (January 10, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0293-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.